
HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY
Description
About HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY
The Human Adenovirus (HAdV) C serotype 1 (HAdV-1) Hexon protein Peptide (IEDB: 134520) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Hexon protein Peptide, H-RTRYFSMWNQAVDSY-OH (Uniprot: Q04965 aa: 273-286) from JPT is produced under strict quality control and quality management.
HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY - Specifications
- Peptide sequence: H-RTRYFSMWNQAVDSY-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY
References:
Read References with JPT’s Antigen Peptides
HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY has been described in:
Generation of cytotoxic T-cell lines using overlapping pentadecapeptides derived from conserved regions of the adenovirus hexon protein., J Gen Virol, 2010 (PMID: 20130135)
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases., Cell Rep Med, 2021 (PMID: 33521695)
Documentation
Documentation for HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY
Properties
Properties of HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Human Adenovirus (HAdV) |
Protein Name: | Hexon protein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HAdV-1 Hexon protein 273-286, RTRYFSMWNQAVDSY
Information | Values |
---|---|
Sequence: | H-RTRYFSMWNQAVDSY-OH |
Specifications: | 15mer peptide as TFA salt |